All Stories

  1. Consumer Perceptions and Behaviors Toward Fermented Foods: Insights From a Canadian Survey
  2. Prebiotic Modulation of FMT Donor Microbiota Enhances MASLD-Relevant Taxa and Functions in an In Vitro Gut Model
  3. Therapeutic properties of plant-derived prebiotics in melanoma
  4. Assessing microbiota in vivo: debugging with medical imaging
  5. TSST-1 promotes colonization of Staphylococcus aureus within the vaginal tract by activation of CD8 + T cells
  6. TSST-1 promotes colonization ofStaphylococcus aureuswithin the vaginal tract by activation of CD8+T cells
  7. Bacterial association with metals enables in vivo monitoring of urogenital microbiota using magnetic resonance imaging
  8. Interconnected microbiomes—insights and innovations in female urogenital health
  9. Magnetic Resonance Imaging of Bacteria: In Vitro Characterization of Lactobacillus Crispatus ATCC33820 at 3T
  10. Predictive Modeling of Urinary Stone Composition Using Machine Learning and Clinical Data: Implications for Treatment Strategies and Pathophysiological Insights
  11. Ethanolamine enhances adhesion, promotes microcompartment formation, and modulates gene expression in Levilactobacillus brevis ATCC 14869
  12. The Microbial Revolution in the World of Joint Replacement Surgery
  13. Predispose, precipitate, perpetuate, and protect: how diet and the gut influence mental health in emerging adulthood
  14. Science around the world
  15. Dissecting mechanisms of fecal microbiota transplantation efficacy in disease
  16. Bacterial association with metals enables in vivo monitoring of microbiota using magnetic resonance imaging
  17. Multi-site microbiota alteration is a hallmark of kidney stone formation
  18. Author Correction: Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
  19. In focus: perplexing increase of urinary stone disease in children, adolescent and young adult women and its economic impact
  20. Assessing the impact of pregnancy and birth factors on the maternal and infant microbiota
  21. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
  22. Delivery mechanism can enhance probiotic activity against honey bee pathogens
  23. Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome
  24. Supplementing Yogurt with Probiotic Bifidobacteria to Counter Chronic Kidney Disease
  25. The Role of Microbiota-Derived Vitamins in Immune Homeostasis and Enhancing Cancer Immunotherapy
  26. The Role of Urinary Modulators in the Development of Infectious Kidney Stones
  27. Osteopontin phosphopeptide mitigates calcium oxalate stone formation in a Drosophila melanogaster model
  28. New perspectives on an old grouping: The genomic and phenotypic variability of Oxalobacter formigenes and the implications for calcium oxalate stone prevention
  29. Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma
  30. Probiotic Bifidobacteria Mitigate the Deleterious Effects of para -Cresol in a Drosophila melanogaster Toxicity Model
  31. Long-Duration Space Travel Support Must Consider Wider Influences to Conserve Microbiota Composition and Function
  32. Drugs, Guts, Brains, but Not Rock and Roll: The Need to Consider the Role of Gut Microbiota in Contemporary Mental Health and Wellness of Emerging Adults
  33. Bacterial association with metals enables in vivo tracking of microbiota using magnetic resonance imaging
  34. Effectiveness of the Lorodent Probiotic Lozenge in Reducing Plaque and Streptococcus mutans Levels in Orthodontic Patients: A Double-Blind Randomized Control Trial
  35. Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial
  36. Safety assessment of Streptococcus salivarius M18 a probiotic for oral health
  37. Why Are Bifidobacteria Important for Infants?
  38. High-Throughput in vitro Gel-Based Plate Assay to Screen for Calcium Oxalate Stone Inhibitors
  39. Emerging connections between gut microbiome bioenergetics and chronic metabolic diseases
  40. The Two-Way Interaction between the Molecules That Cause Vaginal Malodour and Lactobacilli: An Opportunity for Probiotics
  41. Deciphering the low abundance microbiota of presumed aseptic hip and knee implants
  42. Interstrain Variability of Human Vaginal Lactobacillus crispatus for Metabolism of Biogenic Amines and Antimicrobial Activity against Urogenital Pathogens
  43. Meta-analysis on the effect of bacterial interventions on honey bee productivity and the treatment of infection
  44. Fosfowash: Early proof of concept study investigating intravesical fosfomycin for recurrent urinary tract infections
  45. Processing human urine and ureteral stents for 16S rRNA amplicon sequencing
  46. Streptococcus salivarius inhibits immune activation by periodontal disease pathogens
  47. Response to Ianiro et al.
  48. Evaluation of Polyethylene Glycol-Based Antimicrobial Coatings on Urinary Catheters in the Prevention ofEscherichia coliInfections in a Rabbit Model
  49. Young scientist perspective—microbiology trainees and social media: making science go viral during a pandemic
  50. Author Correction: Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
  51. Immunomodulation in Pancreatic Cancer
  52. Oxalate-Degrading Bacillus subtilis Mitigates Urolithiasis in a Drosophila melanogaster Model
  53. Lactobacillus spp. attenuate antibiotic-induced immune and microbiota dysregulation in honey bees
  54. Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
  55. Expired probiotics: what is really in your cabinet?
  56. Issues beyond resistance: inadequate antibiotic therapy and bacterial hypervirulence
  57. Ureteral Stent Microbiota Is Associated with Patient Comorbidities but Not Antibiotic Exposure
  58. Expired Probiotics: What is Really in Your Cabinet?
  59. Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial
  60. Nutritional, Microbial, and Allergenic Changes during the Fermentation of Cashew ‘Cheese’ Product Using a Quinoa-Based Rejuvelac Starter Culture
  61. Current update and future directions on gut microbiome and nephrolithiasis
  62. Potential Role of Extracellular ATP Released by Bacteria in Bladder Infection and Contractility
  63. Novel probiotic approach to counter Paenibacillus larvae infection in honey bees
  64. Deleterious Effects of Neonicotinoid Pesticides on Drosophila melanogaster Immune Pathways
  65. Ibuprofen lacks direct antimicrobial properties for the treatment of urinary tract infection isolates
  66. Response to Long et al regarding: “Cutibacterium acnes and the shoulder microbiome”
  67. Application of Novel 3,4-Dihydroxyphenylalanine-Containing Antimicrobial Polymers for the Prevention of Uropathogen Attachment to Urinary Biomaterials
  68. International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis
  69. The Microbiome and Genitourinary Cancer: A Collaborative Review
  70. Potential role of extracellular ATP released by bacteria in bladder infection and contractility
  71. The Impact of Uremia and Intestinal Dysbiosis on Hepatic Drug Metabolism in a Rat Model of Progressive Chronic Kidney Disease
  72. Immobilization of cadmium and lead by Lactobacillus rhamnosus GR-1 mitigates apical-to-basolateral heavy metal translocation in a Caco-2 model of the intestinal epithelium
  73. Drosophila melanogaster as a function-based high-throughput screening model for antinephrolithiasis agents in kidney stone patients
  74. Cutibacterium acnes and the shoulder microbiome
  75. Moving on from Metchnikoff: thinking about microbiome therapeutics in cancer
  76. Enterococcus faecalis persistence in pediatric patients treated with antibiotic prophylaxis for recurrent urinary tract infections
  77. Inflatable Penile Prostheses Implantation: Does Antibiotic Exposure Matter?
  78. Daily therapy with a slow-releasing H 2 S donor GYY4137 enables early functional recovery and ameliorates renal injury associated with urinary obstruction
  79. Microbiome
  80. Evaluation of sampling and storage procedures on preserving the community structure of stool microbiota: A simple at-home toilet-paper collection method
  81. Transfer of altered behaviour and irritable bowel syndrome with diarrhea (IBS-D) through fecal microbiota transplant in mouse model indicates need for stricter donor screening criteria
  82. Using the Human Gastrointestinal Microbiome to Personalize Nutrition Advice: Are Registered Dietitian Nutritionists Ready for the Opportunities and Challenges?
  83. Super healthy elderly chinese have a 'young' microbiota
  84. Faecal microbiota transplantation: Where did it start? What have studies taught us? Where is it going?
  85. Lactobacillus rhamnosus GR-1 Attenuates Induction of Hypertrophy in Cardiomyocytes but Not through Secreted Protein MSP-1 (p75)
  86. Impact of birth weight and postnatal diet on the gut microbiota of young adult guinea pigs
  87. Impact of birth weight and postnatal diet on the gut microbiota of young adult guinea pigs
  88. Impact of birth weight and postnatal diet on the gut microbiota of young adult guinea pigs
  89. Use of Bacillus in Human Intestinal Probiotic Applications
  90. Extended Screening Costs Associated With Selecting Donors for Fecal Microbiota Transplantation for Treatment of Metabolic Syndrome-Associated Diseases
  91. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs
  92. Questions and challenges associated with studying the microbiome of the urinary tract
  93. Making sense of the urinary microbiota in clinical urology
  94. Efficacy of Probiotic Therapy in Preventing Overt Hepatic Encephalopathy
  95. The oral microbiome of patients with axial spondyloarthritis compared to healthy individuals
  96. Inhibition of Candida albicans biofilm formation and modulation of gene expression by probiotic cells and supernatant
  97. Pathogenic Mechanisms of Uropathogens
  98. Probiotic lactobacilli: a potential prophylactic treatment for reducing pesticide absorption in humans and wildlife
  99. Mycobacterium tuberculosis PE25/PPE41 protein complex induces activation and maturation of dendritic cells and drives Th2-biased immune responses
  100. Microbiota at Multiple Body Sites during Pregnancy in a Rural Tanzanian Population and Effects of Moringa-Supplemented Probiotic Yogurt
  101. Subinhibitory Antibiotic Therapy Alters Recurrent Urinary Tract Infection Pathogenesis through Modulation of Bacterial Virulence and Host Immunity
  102. The microbiome of the urinary tract—a role beyond infection
  103. Inclusion of Fermented Foods in Food Guides around the World
  104. The influence of the human microbiome and probiotics on cardiovascular health
  105. Randomized Open-Label Pilot Study of the Influence of Probiotics and the Gut Microbiome on Toxic Metal Levels in Tanzanian Pregnant Women and School Children
  106. Microbes Central to Human Reproduction
  107. A Systems Biology Approach Investigating the Effect of Probiotics on the Vaginal Microbiome and Host Responses in a Double Blind, Placebo-Controlled Clinical Trial of Post-Menopausal Women
  108. Endogenous biotin expression in renal and testicular tumors and literature review
  109. Effect of chemotherapy on the microbiota and metabolome of human milk, a case report
  110. Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the Rat
  111. Streptococci as Effector Organisms for Probiotic and Replacement Therapy
  112. Microbiota of Human Breast Tissue
  113. Selective Target Inactivation Rather than Global Metabolic Dormancy Causes Antibiotic Tolerance in Uropathogens
  114. High throughput sequencing methods and analysis for microbiome research
  115. Adhesion of Lactobacillus iners AB-1 to Human Fibronectin: A Key Mediator for Persistence in the Vagina?
  116. Persistence of the Oral Probiotic Streptococcus salivarius M18 Is Dose Dependent and Megaplasmid Transfer Can Augment Their Bacteriocin Production and Adhesion Characteristics
  117. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial
  118. If microbial ecosystem therapy can change your life, what's the problem?
  119. Probiotics and nutrients for the first 1000 days of life in the developing world
  120. The Rationale for Probiotics Improving Reproductive Health and Pregnancy Outcome
  121. The Role of the Microbiome in Rheumatic Diseases
  122. Influence of the Vaginal Microbiota on Toxic Shock Syndrome Toxin 1 Production by Staphylococcus aureus
  123. Bioremediation and Tolerance of Humans to Heavy Metals through Microbial Processes: a Potential Role for Probiotics?
  124. Breast, Milk and Microbes: A Complex Relationship that Does Not End with Lactation
  125. Amplification of Oral Streptococcal DNA from Human Incisors and Bite Marks
  126. Effect of Streptococcus salivarius K12 on the In Vitro Growth of Candida albicans and Its Protective Effect in an Oral Candidiasis Model
  127. Salivaricin G32, a Homolog of the PrototypeStreptococcus pyogenesNisin-Like Lantibiotic SA-FF22, Produced by the Commensal SpeciesStreptococcus salivarius
  128. Streptococcus
  129. Genome Sequence of the Bacteriocin-Producing Oral Probiotic Streptococcus salivarius Strain M18
  130. Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: A randomized, placebo-controlled, double-blind study
  131. Beneficial microbes for the oral cavity: time to harness the oral streptococci?
  132. Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius
  133. Probiotic Therapy for the Treatment of Spondyloarthritis: A Randomized Controlled Trial
  134. Is there a correlation between bacterial vaginosis and preterm labour in women in the Otago region of New Zealand?
  135. Extended Safety Data for the Oral Cavity Probiotic Streptococcus salivarius K12
  136. Something Old and Something New: An Update on the Amazing Repertoire of Bacteriocins Produced by Streptococcus salivarius
  137. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics
  138. Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12
  139. A species-specific PCR forLactobacillus inersdemonstrates a relative specificity of this species for vaginal colonization
  140. Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners
  141. Salivaricin A2 and the Novel Lantibiotic Salivaricin B Are Encoded at Adjacent Loci on a 190-Kilobase Transmissible Megaplasmid in the Oral Probiotic Strain Streptococcus salivarius K12
  142. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius
  143. Safety Assessment of the Oral Cavity Probiotic Streptococcus salivarius K12
  144. PCR-DGGE analysis of aspirates from chronic rhinosinusitis patients
  145. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters
  146. Oral streptococcal BLIS: Heterogeneity of the effector molecules and potential role in the prevention of streptococcal infections
  147. Non-Culture-Based Analysis of Bacterial Populations from Patients with Chronic Rhinosinusitis
  148. A preliminary survey of Atopobium vaginae in women attending the Dunedin gynaecology out‐patients clinic: Is the contribution of the hard‐to‐culture microbiota overlooked in gynaecological disorders?
  149. O17 Effect of Probiotic Streptococcus salivarius K12 on oral malodour parameters
  150. The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics
  151. Novel insight into the vaginal microflora in postmenopausal women under hormone replacement therapy as analyzed by PCR-denaturing gradient gel electrophoresis
  152. Nucleic Acid-Based Diagnosis of Bacterial Vaginosis and Improved Management Using Probiotic Lactobacilli
  153. Detection of Atopobium vaginae in Postmenopausal Women by Cultivation-Independent Methods Warrants Further Investigation
  154. Surface‐enhanced laser desorption/ionization‐time of flight‐mass spectrometry (SELDI‐TOF‐MS): A new proteomic urinary test for patients with urolithiasis
  155. Atomic force microscopic and encrustation studies of novel prospective polyisobutylene‐based thermoplastic elastomeric biomaterials
  156. Evaluation of QIAamp® DNA Stool Mini Kit for ecological studies of gut microbiota
  157. Oxalate-Degrading Enzymes fromOxalobacter formigenes: A Novel Device Coating to Reduce Urinary Tract Biomaterial-Related Encrustation
  158. Detection of Bifidobacterium species and Gardnerella vaginalis in the vagina using PCR and denaturing gradient gel electrophoresis (DGGE)
  159. Digoxigenin-labelled peptide nucleic acid to detect lactobacilli PCR amplicons immobilized on membranes from denaturing gradient gel electrophoresis
  160. Improved Understanding of the Bacterial Vaginal Microbiota of Women before and after Probiotic Instillation
  161. Evaluation of the Bacterial Vaginal Flora of 20 Postmenopausal Women by Direct (Nugent Score) and Molecular (Polymerase Chain Reaction and Denaturing Gradient Gel Electrophoresis) Techniques
  162. Identification, Detection, and Enumeration of Human Bifidobacterium Species by PCR Targeting the Transaldolase Gene
  163. Lactobacillus Strains and Vaginal Ecology
  164. Use of Lactobacillus to prevent infection by pathogenic bacteria
  165. Properties of Porcine and Yogurt Lactobacilli in Relation to Lactose Intolerance